CANNABIDIOL (CBD) IS A POWERFUL NEW ANTIBIOTIC
An article published on Neuroscience News. Com reported that CBD is a powerful new antibiotic. I will use much of that article here. The research, led by Dr. Mark Blaskovich at the University of Queensland’s Institute for Molecular Bioscience’s Center for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, found that CBD was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics.
CBD HAS A SIMILAR POTENCY TO ESTABLISHED ANTIBIOTICS
The new research indicates that CBD is active against infections such as Staphyloccocus aureus and Streptococcus pneumoniae and that it has a potency similar to that of established antibiotics such as vancomycin or daptomycin.
CBD RETAINS ITS POTENCY, UNLIKE OTHER ANTIBIOTICS
CBD was found to be effective against Gram-positive bacteria, including bacteria that have become resistant to other antibiotics. In addition, CBD did not lose its effectiveness after extended treatment. The article states, the study found that, “…under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.”
CBD IS A PROMISING NEW ANTIBIOTIC
Dr. Mark Blaskovich stated, “Given cannabidiol’s (CBD) anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation.”
THE RESEARCH PAPER WAS PRESENTED IN JUNE
The paper on this research was presented in June at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco. This is promising news and as further research in competed, we will be able to conclusively state that CBD will be used as a powerful antibiotic.